About us

AtG Therapeutics is a pre-clinical stage drug development company specialized in the discovery of tumor vulnerabilities and the development of therapeutics and biomarkers to treat advanced cancer.

Build a pipeline of tumor adaptation 
inhibitors and biomarkers  
to stop cancer growth over time

Recognition

The novelty and the potential impact of the AtG project has been recognized by several entities at a national and international level.

European Research Council (ERC)

Learn more